Monthly Mircera (methoxy PEG-epoetin beta) Versus Epoetin Alfa in Peritoneal Dialysis Patients
Anemia
Enrolment: 80 · Results not recorded
Biologic · Erythropoietin receptor agonist (AGONIST); continuous erythropoietin receptor activator
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Anemia
Enrolment: 80 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Medium-dose cyclosporine A exposure for 28 days, producing acute renal tubulo-interstitial injury with macrophage sequestration and pancreatic islet cell damage
Cyclosporine A induced functional kidney damage that low-dose CERA did not improve. CERA showed a trend to osteopontin upregulation with increased renal macrophage infiltration and enhanced parenchymal transforming growth factor beta 1 and interleukin-10 relative to controls, and ameliorated pancre…
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.